Correlation Between Veracyte and Alx Oncology
Can any of the company-specific risk be diversified away by investing in both Veracyte and Alx Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Alx Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Alx Oncology Holdings, you can compare the effects of market volatilities on Veracyte and Alx Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Alx Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Alx Oncology.
Diversification Opportunities for Veracyte and Alx Oncology
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Veracyte and Alx is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Alx Oncology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alx Oncology Holdings and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Alx Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alx Oncology Holdings has no effect on the direction of Veracyte i.e., Veracyte and Alx Oncology go up and down completely randomly.
Pair Corralation between Veracyte and Alx Oncology
Given the investment horizon of 90 days Veracyte is expected to generate 0.53 times more return on investment than Alx Oncology. However, Veracyte is 1.88 times less risky than Alx Oncology. It trades about 0.04 of its potential returns per unit of risk. Alx Oncology Holdings is currently generating about -0.03 per unit of risk. If you would invest 2,913 in Veracyte on September 4, 2024 and sell it today you would earn a total of 1,499 from holding Veracyte or generate 51.46% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Veracyte vs. Alx Oncology Holdings
Performance |
| Timeline |
| Veracyte |
| Alx Oncology Holdings |
Veracyte and Alx Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Veracyte and Alx Oncology
The main advantage of trading using opposite Veracyte and Alx Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Alx Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alx Oncology will offset losses from the drop in Alx Oncology's long position.| Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
| Alx Oncology vs. Cabaletta Bio | Alx Oncology vs. Viracta Therapeutics | Alx Oncology vs. Eyepoint Pharmaceuticals | Alx Oncology vs. Biomea Fusion |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |